fbpx
Connect with us

News

Irish oncology care platform teams up with NCCN to develop digital tool

Published

on

ONCOassist is currently the only oncology app with regulatory approval for use in a hospital setting

The Irish oncology software company ONCOassist has announced an agreement with the National Comprehensive Cancer Network to develop a digital tool to help healthcare professionals.

The collaboration will focus on integrating NCCN content to create a tool to support oncology professionals stay up to date with relevant clinical content about cancer care.

ONCOassist, a CE-approved decision support app for oncology professionals, is currently the only oncology app on the market with regulatory approval for use in a hospital setting.

The company hosts tools and content specific to oncology and is used by more than 73,000 professionals – around 40 per cent of oncology healthcare experts (HCPs) globally.

By joining forces, the not-for-profit alliance NCCN will enable ONCOassist to make key decision support information available to their users around the world, advancing their mission of helping HCPs make more informed oncology decisions.

The agreement will allow clinicians to access up-to-date tools and content on the ONCOassist app.

According to Cancer Research UK, there are around 375,000 new cancer cases in the UK every year.

Globally, more than 18 million cases of cancer were diagnosed in 2020 alone, according to the World Cancer Research International Fund.

DATA-CAN, the UK’s health data research hub for cancer, found that there was a significant drop in urgent referrals for early cancer diagnosis along with a noticeable reduction in chemotherapy attendance during the Covid pandemic.

This suggests that Covid may have impacted and prevented patients from being diagnosed early on.

Eoin O’Carroll, co-founder and CEO of ONCOassist, said: “We are thrilled to announce this opportunity to collaborate with the NCCN.

“This project has been in the pipeline for some time and we are very much looking forward to working together.

“This is an exciting step forward for ONCOassist for our work in cancer care and goal to facilitate healthcare professionals by gaining access to the right information and delivering better care to patients,” he added.

Robert W. Carlson, CEO of NCCN, said: ”Clinicians need to have frequently-updated, evidence-based, expert consensus information available at their fingertips.

“This collaboration will help make sure the gold-standard recommendations from NCCN’s expert panels are easily accessible to the people who need them. Ultimately, this means more people with cancer will receive the kind of treatment that is most likely to lead to better outcomes.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories